Ascendis Pharma A/S (ASND)
NASDAQ: ASND · IEX Real-Time Price · USD
133.75
-0.63 (-0.47%)
Jul 26, 2024, 4:00 PM EDT - Market closed

Ascendis Pharma Statistics

Total Valuation

ASND has a market cap or net worth of $7.57 billion. The enterprise value is $7.95 billion.

Market Cap 7.57B
Enterprise Value 7.95B

Important Dates

The next estimated earnings date is Tuesday, September 3, 2024, after market close.

Earnings Date Sep 3, 2024
Ex-Dividend Date n/a

Share Statistics

ASND has 56.61 million shares outstanding.

Shares Outstanding 56.61M
Owned by Insiders (%) 0.76%
Owned by Institutions (%) 107.64%
Float 56.90M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 21.17
Forward PS 14.44
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 22.23
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.83

Current Ratio 0.83
Quick Ratio 0.49
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -3.13

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -60.30%
Return on Capital (ROIC) -83.79%
Revenue Per Employee $406,864
Profits Per Employee -$620,232
Employee Count 879
Asset Turnover 0.40
Inventory Turnover 0.25

Taxes

In the past 12 months, ASND has paid $9.24 million in taxes.

Income Tax 9.24M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +54.32% in the last 52 weeks. The beta is 0.63, so ASND's price volatility has been lower than the market average.

Beta (5Y) 0.63
52-Week Price Change +54.32%
50-Day Moving Average 132.44
200-Day Moving Average 128.04
Relative Strength Index (RSI) 47.40
Average Volume (20 Days) 270,158

Short Selling Information

Short Interest 3.45M
Short Previous Month 3.54M
Short % of Shares Out 8.67%
Short % of Float n/a
Short Ratio (days to cover) 12.18

Income Statement

In the last 12 months, ASND had revenue of $357.63 million and -$545.18 million in losses. Loss per share was -$9.63.

Revenue 357.63M
Gross Profit 305.78M
Operating Income -391.89M
Pretax Income -535.25M
Net Income -545.18M
EBITDA -385.13M
EBIT -405.59M
Loss Per Share -$9.63
Full Income Statement

Balance Sheet

The company has $347.64 million in cash and $726.26 million in debt, giving a net cash position of -$378.62 million or -$6.69 per share.

Cash & Cash Equivalents 347.64M
Total Debt 726.26M
Net Cash -378.62M
Net Cash Per Share -$6.69
Equity (Book Value) -258.56M
Book Value Per Share -4.57
Working Capital -146.40M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$458.00 million and capital expenditures -$1.63 million, giving a free cash flow of -$459.64 million.

Operating Cash Flow -458.00M
Capital Expenditures -1.63M
Free Cash Flow -459.64M
FCF Per Share -$8.08
Full Cash Flow Statement

Margins

Gross margin is 85.50%, with operating and profit margins of -109.58% and -152.44%.

Gross Margin 85.50%
Operating Margin -109.58%
Pretax Margin -149.66%
Profit Margin -152.44%
EBITDA Margin -107.69%
EBIT Margin -113.41%
FCF Margin -128.52%

Dividends & Yields

ASND does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.41%
Shareholder Yield -1.41%
Earnings Yield -7.20%
FCF Yield -6.07%
Dividend Details

Analyst Forecast

The average price target for ASND is $186.33, which is 39.31% higher than the current price. The consensus rating is "Strong Buy".

Price Target $186.33
Price Target Difference 39.31%
Analyst Consensus Strong Buy
Analyst Count 9
Revenue Growth Forecast (5Y) 56.74%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

ASND has an Altman Z-Score of 2.26 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.26
Piotroski F-Score 3